Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467733) titled 'Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy' on March 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Biocells Medical
Condition:
Spinocerebellar Ataxia - All Sub-types
Intervention:
Drug: Intrathecal infusion
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: June 1, 2026
Target Sample Size: 90
Countries of Recruitmen...